FERRANTI, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 1.349
EU - Europa 554
AS - Asia 301
SA - Sud America 9
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.220
Nazione #
US - Stati Uniti d'America 1.320
IT - Italia 152
UA - Ucraina 135
IN - India 117
SG - Singapore 110
SE - Svezia 89
CN - Cina 73
FI - Finlandia 60
GB - Regno Unito 30
DE - Germania 28
CA - Canada 25
BG - Bulgaria 16
AT - Austria 14
IE - Irlanda 9
BE - Belgio 7
AR - Argentina 6
TG - Togo 5
MX - Messico 4
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
GR - Grecia 2
NL - Olanda 2
RU - Federazione Russa 2
AU - Australia 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
NO - Norvegia 1
PT - Portogallo 1
VN - Vietnam 1
Totale 2.220
Città #
Chandler 189
Fairfield 98
Ashburn 89
Singapore 76
Woodbridge 63
Seattle 61
Princeton 56
Ann Arbor 55
Plano 54
Wilmington 54
Beijing 52
Rome 51
Dearborn 47
Jacksonville 46
Des Moines 36
Houston 35
Boston 31
Cambridge 30
Millbury 22
Pune 16
Sofia 15
Toronto 13
Bremen 12
San Paolo di Civitate 12
San Diego 11
Vienna 11
Dublin 9
Santa Clara 9
Andover 8
Southend 8
Auburn Hills 7
Brussels 7
Lawrence 7
Boardman 6
Federal 6
Fremont 6
Helsinki 6
Norwalk 6
Bühl 5
Formello 5
Kunming 5
Lomé 5
Alexandria 4
Hefei 4
Los Angeles 4
Mannheim 4
Mexico City 4
Falls Church 3
Florence 3
Milan 3
Americana 2
Bern 2
Bologna 2
Caserta 2
Frosinone 2
Jinan 2
Montréal 2
Naples 2
Prineville 2
Quzhou 2
Redmond 2
San Mateo 2
Tuttlingen 2
Udine 2
Venezia 2
Verbania 2
Verona 2
Angri 1
Buffalo 1
Capodrise 1
Changsha 1
Coominya 1
Cutrofiano 1
Dallas 1
Ercolano 1
Flushing 1
Fuzhou 1
Genivolta 1
Glasgow 1
Guangzhou 1
Hangzhou 1
Jiaxing 1
Kilburn 1
Langfang 1
Las Vegas 1
Laurel 1
Leipzig 1
Marina Di Gioiosa Ionica 1
Nanjing 1
Napoli 1
Newark 1
Nocera Inferiore 1
Ottawa 1
Palermo 1
Philadelphia 1
Phoenix 1
Pisa 1
Pomezia 1
Portland 1
Provo 1
Totale 1.436
Nome #
Studio delle sindromi mielodisplastiche in citometria a flusso a 10 colori 97
Activated and "memory" phenotype of circulating T lymphocytes in intrauterine life 73
Clonal evolution in Philadelphia chromosome negative cells following successful treatment with imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome 67
Valuation of MCP-1 and VEGF Chemokines In Serum of Patients with AL Amyloidosis 66
Diagnosi prenatale non invasiva 63
Duplication 3p and cyclopia. 63
CITOGENETICA CONVENZIONALE E MOLECOLARE SU 100 PAZIENTI CON LEUCEMIA LINFATICA CRONICA 61
una rete di laboratori ed ospedali per migliorare la qualità delle prestazioni sanitarie in italia.esperienza dei centri gimema 59
IL-4 and IL-1 Serum Levels In Systemic and Localized Amyloidosis 57
Microdelezione del cromosoma Y in soggetti con oligo/azoospermia idiopatica 56
Heart Function In Systemic and Localized AL Amyloidosis: Role of NT-ProBNP and MPC-1 54
MR-proANP and MCP-1 as effective biomarkers of cardiac and microvascular inflammatory impairment in systemic AL amyloidosis patients treated with MEL-DEX association. 53
IL6 and IL10 activity in patients with carotid artery stenting (CAS) 51
Diagnosi prenatale non invasiva: isolamento di eritrociti nucleati fetali da sangue materno mediante micromanipolazione. 49
Prenatal diagnosis of terminal deletion 1 (q42) 49
Osteocalcin and free light chain levels in amyloidosis 49
NT-ProBNP and VEGF Serum Evaluation In AL Amyloidosis 47
Diagnosi differenziale ecografica delle anomalie della regione nucale nel primo e nel secondo trimestre di gravidanza 44
Fetal stem cell culture characterization in maternal blood for non invasive prenatal diagnosis 44
TH1/TH2 balance in a patient with amyotrophic lateral sclerosis (ALS) 44
Fetal cells in maternal circulation 43
First-trimester prenatal diagnosis of homozygous (14;21) translocation in a fetus with 44 chromosomes. 42
Cyrculating levels of vascular endothelial growth factor (VEGF) in patients with carotid artery stenting (CAS) 42
Fetal stem cells in maternal blood for non-invasive prenatal diagnosis. 42
CYSTATIN C, B2-MICROGLOBULIN AND ALKALINE PHOSPHATASE SERUM LEVELS IN AL AMYLOIDOSIS 41
Valutazione di markers tumorali nel liquido cefalorachidiano (CSF) 38
Identificazione di mutazioni nel gene hMRE11 in pazienti ATLD con Atassia senza Telangectasia 37
Caratterizazione di cellule emopoietiche fetali presenti nel circolo materno per una diagnosi prenatale non invasiva. 37
Prenatal sex determination by DNA amplification from maternal serum 36
Development of non invasive fetal DNA diagnosis from maternal blood by micromanipulation 36
Correlation between serum levels of free light chain and circulating cytokines in a patient with AL cardiac amyloidosis 36
Clinical role of IL-6 and IL-1B in IgG and IgA multiple myeloma 36
DOSAGGIO DELLE MOLECOLE DI ADESIONE IN PAZIENTI CON CRIOGLOBULINEMIA 36
MCP-1 and VGEF markers in the evaluation of systemic AL amyloidosis response to Upfront Melphalan-Dexamethasone Association. 35
DIFFERENCE IN SERUM CYTOKINES PATTERN BETWEEN SYSTEMIC AND LOCALIZED AL AMYLOIDOSIS 35
Mid-region pro-adrenomedullin (MR-PROADM) and homocysteine serum evaluation in HIV infection. 34
FISH-MLL abnormalities in patients with acute myeloblastic leukemia and association with FLT3 and Mll internal duplication 34
Use of the Troponin-I (cTn-I): an experience of one year 33
Constitutional trisomy 8 in myelodysplstic syndromes and acute myeloid leukemia.Citogenetic findings in five patients 32
Renal function improvement evaluated by cystatin-C serum levels in patients with systemic AL amyloidosis treated with MEL-DEX association 32
Riflessioni sui trattamenti per l'infertilità e la possibile insorgenza di carcinomi ovarici 32
Migrazione atipica di una componente monoclonale (CM) in regione alfa-2 rilevata mediante elettroforesi capillare (CE) in una paziente con mieloma multiplo asintomatico 32
Variation of the principal electrolytes in cerebrospinal fluid(CSF) and serum of patients with multiple sclerosis 30
Dosaggio in diagnostica sierologica delle catene leggere libere nell’infezione sostenuta dal virus HIV 30
MULTIPLE MYELOMA AND MGUS: A SERUM EVALUATION OF PCT, MR-PROAMD AND MR PROANP 29
NGF receptor expression on uncultured amniotic fluid cells and NGF levels in amniotic fluid in 3 cases of anencephaly. 28
Interference of medium contrast in serum capillary electrophoresis: a case-report 26
SERUM LEVELS OF MR-PROANP IN HIV AND HCV PATIENTS WITHOUT CRYOGLOBULINEMIA 26
MR-PROADM as marker of vascular damage reversibility in AL amyloidosis patients. 25
MR-ProANP: A POSSIBLE ADDITIONAL CARDIAC MARKER IN AL AMYLOIDOSIS 24
TH1 and TH2 cells in multiple myeloma 23
Valutazione sierologica delle catene leggere libere kappa e lambda in soggetti con infezione da virus HCV e crioglobulinemia di tipo II e III 23
Non invasive genetic prenatal diagnosis from maternal blood using stem cells. 21
THE SERUM LEVELS OF MR-proANP IN PATIENTS HCV POSITIVE WITH AND WITHOUT CRYOGLOBULINEMIA 19
The role of high-sensitivity C-reactive protein (HS-CRP) and mid-region pro-adrenomedullin (MR-PROADM) in HIV infect patients 3
Totale 2.254
Categoria #
all - tutte 6.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020335 0 0 2 26 27 74 57 43 27 37 34 8
2020/2021134 24 17 6 9 2 20 4 18 6 18 8 2
2021/2022403 4 25 26 8 64 5 3 47 23 46 48 104
2022/2023576 107 52 39 80 74 92 4 23 73 4 22 6
2023/2024275 15 44 4 12 25 68 5 31 0 32 24 15
2024/202588 26 62 0 0 0 0 0 0 0 0 0 0
Totale 2.254